ss 31 peptide kidney SS-31 is a peptide used to target mitochondria - SS-31peptideprotocol SS-31 has protective benefits on glomerular mitochondria

SS-31peptidereview The SS-31 peptide, also known by its investigational drug name Elamipretide, is a mitochondria-targeting therapeutic agent that has demonstrated significant promise in ameliorating kidney damage. Research indicates that SS-31 functions by protecting mitochondria, the powerhouses of cells, from oxidative stress and dysfunction, thereby improving renal function and offering protective benefits against various forms of kidney injury. This peptide's ability to reduce reactive oxygen species (ROS) and stabilize mitochondrial structure makes it a key focus in studies exploring treatments for conditions like diabetic nephropathy and acute kidney injury.作者：JC Wyss·2019·被引用次数：22—The mitochondria-active tetrapeptide SS-31can control oxidative tissue damage in kidney diseases. To investigate other potential beneficial nephroprotective ...

Understanding SS-31's Mechanism in Kidney Health

SS-31 is a small, cell-permeable tetrapeptide specifically designed to accumulate in the inner mitochondrial membrane2023年9月17日—SS-31 is a peptide used to target mitochondria, and it has been found to protect the kidneys from oxidative stress, inflammation and apoptosis.. Its primary mechanism of action involves enhancing mitochondrial function and integrity, particularly under conditions of cellular stress or injury. By targeting mitochondria, SS-31 can reduce the production of damaging ROS, a common culprit in the progression of kidney diseases. Studies have shown that SS-31 can protect glomerular mitochondria and improve mitochondrial dynamics, which are crucial for maintaining healthy kidney tissue. This targeted approach helps to mitigate oxidative tissue damage and inflammation, leading to improved kidney health.

Applications in Kidney Disease Management

The therapeutic potential of SS-31 peptide in kidney disease is a growing area of researchSS31 protects the brain against neurodegeneration. It actually protects the kidney if there's any kind of kidney damage or kidney injury. It .... It has shown efficacy in ameliorating renal tubulointerstitial injury in models of diabetic nephropathy. By preventing oxidative stress and downregulating specific cellular markers like CD36, SS-31 has been observed to improve overall renal function in these contexts.2023年9月17日—SS-31 is a peptide used to target mitochondria, and it has been found to protect the kidneys from oxidative stress, inflammation and apoptosis. Furthermore, SS-31 is being investigated for its role in preventing acute kidney injury, including that induced by contrast agents used in medical imaging, particularly in diabetic patients.作者：D Liu·2019·被引用次数：158—Mitochondria-targeted peptide SS-31 attenuates renal injuryvia an antioxidant effect in diabetic nephropathy. Am. J. Physiol. Renal. Physiol., 310 (6) (2016). Its ability to protect mitochondrial function and inhibit inflammatory signaling pathways like NLRP3 is central to these protective effects.

Clinical Trials and Future Prospects

SS-31 is currently undergoing clinical trials for a range of mitochondrial disorders, including conditions affecting the kidneys. Its potential extends beyond direct kidney protection to broader cardiovascular health, with investigations into its role in preventing atherosclerotic progression, which can impact renal arteries.SS-31 protects diabetic nephropathy progression The peptide's demonstrated capacity to improve kidney mitochondrial function, reduce inflammation, decrease fibrosis, and enhance ATP production suggests a significant role in future therapeutic strategies for chronic kidney disease (CKD) and other renal pathologies. As research progresses, SS-31 represents a promising therapeutic avenue for preserving kidney health and function.